FRESENIUS KABI DEUTSCHLAND GMBH

Fresenius Kabi is a global pharmaceutical and medical technology leader headquartered in Bad Homburg, Germany, with over 41,000 employees serving 450 million patients annually across 150+ countries. Founded in 1912, the company specializes in lifesaving medicines and technologies for critically and chronically ill patients. Its core portfolio encompasses infusion therapy products (IV generics, infusion solutions), clinical nutrition (enteral and parenteral nutrition, including the Fresubin® brand with 50 years of innovation), transfusion technologies (blood collection and processing systems), and complementary medical devices. The company operates four key business segments focused on delivering reliable supply chains and evidence-based therapeutic solutions for healthcare providers in ICU, critical care, and chronic disease management settings.